CERVICAL CANCER SCREENING AND ASSOCIATED FACTORS AMONG WOMEN OF REPRODUCTIVE AGE IN LHOKSEUMAWE, ACEH
Downloads
Cervical cancer is the second most prevalent cause of cancer-related mortality among women worldwide. Indonesia has the second-highest incidence of cervical cancer worldwide. The etiology of cervical cancer in women is multifactorial. This study aimed to investigate the Pap smear screening tests and analyze the risk factors associated with cervical cancer in women of reproductive age in Lhokseumawe, Aceh, Indonesia. This quantitative study used a cross-sectional design. The data source comprised secondary data collected between January and September 2023 at a clinical laboratory in Lhokseumawe, Aceh, Indonesia. The study sample consisted of 100 women who underwent the Pap smear test. The independent variables examined were age, age at first childbirth, age at menarche, parity, menstrual cycle, history of contraceptive use, and history of miscarriage, whereas the dependent variable was the Pap smear test results. Chi-square analysis demonstrated significant correlations between miscarriage history (p=0.05), parity (p=0.001), menstrual cycle duration (p=0.049), and Pap smear cytological results. Logistic regression revealed that women with a previous miscarriage, more than two children, and menstrual cycles exceeding 28 days were 3.46, 1.32, and 2.53 times more likely, respectively, to have abnormal Pap smear results. Therefore, high-risk women should undergo regular cervical cancer screening to detect the precancerous lesions.
World Health Organization. Reproductive health in the South-East Asia Region. Geneva, Switzerland; 2019 [cited 2024 Apr 26]. Available from: https://www.who.int/southeastasia/health-topics/reproductive-health
Global Cancer Observatory. Global Cancer Observatory. 2022 [cited 2024 Jan 19]. Available from: https://gco.iarc.fr/en
East Java Provincial Health Office. Health Profile of East Java Province in 2019. 2019 [cited 2024 May 26]. Available from: https://dinkes.jatimprov.go.id/userfile/dokumen/Profil%20Kesehatan%20Jatim%202019.pdf
American Cancer Society. Signs and Symptoms of Cervical Cancer. 2024 [cited 2024 Nov 20]. Available from: https://www.cancer.org/cancer/types/cervical-cancer/detection-diagnosis-staging/signs-symptoms.html
Gitonga E, Iseme R, Mutisya R, Kodhiambo M. Cervical cancer knowledge, awareness and related health behaviours amongst women of reproductive age in Kiambu County, Kenya: a cross-sectional study. Health Psychol Behav Med. 2022;10(1):1056–70.
Riani EN, Ambarwati D. Early detection kanker serviks sebagai upaya peningkatan derajat hidup perempuan. SELAPARANG: Jurnal Pengabdian Masyarakat Berkemajuan. 2021;3(2):144–6.
Nathasya Karren Zeta NKZ, Oktarlina RZ, Ramdini DA, Wardhana MF. Relationship between parity and cervical cancer: literature review. Medical Profession Journal of Lampung. 2023 Apr 11;13(4):490–4.
Analysa A, Lestari DPO, Artha IGA. Overexpression of PDL-1 is a risk factor for lymph node metastasis in cervical cancer. International Journal of Health & Medical Sciences. 2023;6(2):69–76.
Robbers G, Bennett LR, Spagnoletti BRM, Wilopo SA. Facilitators and barriers for the delivery and uptake of cervical cancer screening in Indonesia: A Sscoping review. Glob Health Action. 2021;14(1).
Agustiansyah P, Sanif R, Nurmaini S, Irfannuddin I, Legiran N. Epidemiology and risk factors for cervical cancer. Bioscientia Medicina Journal of Biomedicine and Translational Research. 2021;5(7):624–31.
Canfell K. Towards the global elimination of cervical cancer. Papillomavirus Research. 2019;8:100170.
Setiawan D, Andrijono, Hadinegoro SR, Meyta H, Sitohang R, Tandy G, et al. Cervical cancer prevention in Indonesia: an updated clinical impact, cost-effectiveness and budget impact analysis. PLoS One. 2020;15(3):e0230359.
Sumarmi S, Hsu YY, Cheng YM, Lee SH. Factors associated with the intention to undergo Pap smear testing in the rural areas of Indonesia: a health belief model. Reprod Health. 2021;18(1):138.
Febrianti R, Wahidin M. Faktor–faktor yang mempengaruhi pemeriksaan Pap Smear pada wanita usia subur di Poliklinik Kebidanan Rumah Sakit Umum Daerah Abdul Manap Kota Jambi. Bunda Edu-Midwifery Journal (BEMJ). 2020;3(1):1–10.
Sumarmi S, Hsu YY, Cheng YM, Lee SH. Factors associated with the intention to undergo Pap smear testing in the rural areas of Indonesia: a health belief model. Reprod Health. 2021;18(1):138.
Latifah L, Nurachmah E, Hiryadi H. Faktor yang berkontribusi terhadap motivasi menjalani pemeriksaan pap smear pasien kanker serviks di poli kandungan. Jurnal Keperawatan Suaka Insan (JKSI). 2020;5(1):90–9.
Endriani TI, Budiana ING, Mahendra INB, Surya IGNHW. Karakteristik hasil Pap Smear menurut Bethesda di RSUP Sanglah Denpasar Tahun 2016-2017. Jurnal Medika Udayana. 2021;10(1):77–81.
Marcus JZ, Cason P, Downs Jr LS, Einstein MH, Flowers L. The ASCCP Cervical Cancer Screening Task Force endorsement and opinion on the American Cancer Society updated cervical cancer screening guidelines. J Low Genit Tract Dis. 2021;25(3):187–91.
Okunade KS. Human papillomavirus and cervical cancer. J Obstet Gynaecol (Lahore). 2020;40(5):602–8.
Wulan RN. Cervical cancer in women of childbearing age. Journal of Applied Transintegration Paradigm. 2022;2(02):71–84.
Yuliawati Y, Martini M, Widiyanti S. Correlations between the age of first married, contraception use and family history with cervical precancer in women of childbearing age at Metro City Health Center. Science Midwifery. 2022;10(2):1124–9.
Anastasiou E, McCarthy KJ, Gollub EL, Ralph L, van de Wijgert JHHM, Jones HE. The relationship between hormonal contraception and cervical dysplasia/cancer controlling for human papillomavirus infection: A systematic review. Contraception. 2022;107:1–9.
Roura E, Travier N, Waterboer T, De Sanjosé S, Bosch FX, Pawlita M, et al. The influence of hormonal factors on the risk of developing cervical cancer and pre-cancer: results from the EPIC cohort. PLoS One. 2016;11(1):e0147029.
Gul S, Ali T, Bibi R, Hanif S, Gul S, Farooqi K. Association between hormonal contraceptives and cervical neoplasia in local population of Khyber Pakhtunkhwa. PJMHS. 2022;16(9):489–91.
Kashyap N, Krishnan N, Kaur S, Ghai S. Risk factors of cervical cancer: A case-control study. Asia Pac J Oncol Nurs. 2019;6(3):308–14.
Wulandari V. Correlation Between Oral Contraceptives Use and Sexual Activity with Cervical Cancer. Jurnal Berkala Epidemiologi. 2016;4(3):432–42.
Shen CT, Tai SY, Tsao YH, Chen FM, Hsieh HM. Abortion and female cancer risks among women aged 20 to 45 years: A 10-year longitudinal population-based cohort study in Taiwan. Int J Environ Res Public Health. 2023;20(4):3682.
Imelda F, Nasution DL. Correlations among age, parity, and contraception using with Pap Smear results in Medan, Sumatera. Indian J Public Health Res Dev. 2020;11(6):1247–51.
Khumthong K, Aue-aungkul A, Kleebkaow P, Chumworathayi B, Temtanakitpaisan A, Nhokaew W. Association of abnormal Pap smear with occult cervical stromal invasion in patients with endometrial cancer. Asian Pacific Journal of Cancer Prevention. 2019;20(9):2847–50.
Lelly E. Faktor risiko kanker serviks pada wanita lanjut usia di RSD Gunung Jati Kota Cirebon. Jurnal Health Sains. 2020;1(1):1–7.
Astrid Savitri D. Kupas tuntas kanker payudara, leher rahim, dan rahim. Yogyakarta. Pustaka Baru Press; 2015.
Tekalegn Y, Sahiledengle B, Woldeyohannes D, Atlaw D, Degno S, Desta F, et al. High parity is associated with increased risk of cervical cancer: Systematic review and meta-analysis of case–control studies. Women’s Health. 2022;18:17455065221075904.
Varghese H, Qureshi MAS, Ronghe A, Vyas A, Singh R, Chamarti K. Prevalence and sociodemographic covariates of cervical cancer and its association with menstrual irregularities: Findings from the 2017 national inpatient sample database. Cureus. 2021;13(10).
Vashishta S, Gahlot S. A study on body mass index and menstrual cycle length in reproductive age women. International Journal of Advances in Medicine. 2022;9(2):130.
Okodo M, Okayama K, Tsukakoshi N, Misawa Y, Tanabe K, Teruya K, et al. Effects of menstrual cycle on various morphologies of high-grade squamous intraepithelial lesions in SurePathTM liquid-based cervical cytology. Acta Cytol. 2022;66(6):507–12.
Antwi MH, Appiah SCY. Prevalence of unsatisfactory Pap smear and associated clinical History and diagnosis in a tertiary teaching Hospital in Ghana. J Biomed Sci Eng. 2019;12(06):311–21.
Wang S, Wang YX, Sandoval-Insausti H, Farland L V, Shifren JL, Zhang D, et al. Menstrual cycle characteristics and incident cancer: a prospective cohort study. Human Reproduction. 2022;37(2):341–51.
Copyright (c) 2024 Jurnal Biometrika dan Kependudukan (Journal of Biometrics and Population)
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Copyright ©2022 Jurnal Biometrika dan Kependudukan (Journal of Biometrics and Population)
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
1. Copyright of all journal manuscripts is held by the Jurnal Biometrika dan Kependudukan.
2. Formal legal provisions to access digital articles of the electronic journals are subject to the provision of the Creative Commons Attribution-ShareAlike license (CC BY-NC-SA), which means that Jurnal Kesehatan Biometrika dan Kependudukan to keep, transfer media/format, manage in the form of databases, maintain, and publish articles.
3. Published manuscripts both printed and electronic are open access for educational, research, and library purposes. Additionally, the editorial board is not responsible for any violations of copyright law.
